Skip to main content
. 2018 Oct 30;9:4515. doi: 10.1038/s41467-018-06924-5

Fig. 6.

Fig. 6

HDAC2f/f CD4-Cre mice show enhanced colitis. Data shows a survival curve (%) (n= 12 per group), b percentage change in body weight, c FOB score, d diarrhea score, and e, f colon length of WT mice and HDAC2f/f CD4-Cre mice (n= 6 per group) after intrarectal administration of 2.5% TNBS. g Real-time PCR and ELISA were used to analyze IL-17A expression in WT mice and HDAC2f/f CD4-Cre mice given TNBS. h H&E-stained colonic sections and i disease scores of those sections are shown from WT mice and HDAC2f/f CD4-Cre mice as in ad (n = 4). Data are from one experiment representative of three independent experiments with similar results. *p< 0.05 and **p< 0.01 (two-tail t test) error bars are S.D.